RNA sequestration in P-bodies sustains myeloid leukaemia

P小体中RNA的滞留维持着髓系白血病。

阅读:2
作者:Srikanth Kodali # ,Ludovica Proietti # ,Gemma Valcarcel ,Anna V López-Rubio ,Patrizia Pessina ,Thomas Eder ,Junchao Shi ,Annie Jen ,Núria Lupión-Garcia ,Anne C Starner ,Mason D Bartels ,Yingzhi Cui ,Caroline M Sands ,Ainoa Planas-Riverola ,Alba Martínez ,Talia Velasco-Hernandez ,Laureano Tomás-Daza ,Bernhard Alber ,Gabriele Manhart ,Isabella Maria Mayer ,Karoline Kollmann ,Alessandro Fatica ,Pablo Menendez ,Evgenia Shishkova ,Rachel E Rau ,Biola M Javierre ,Joshua Coon ,Qi Chen ,Eric L Van Nostrand ,Jose L Sardina ,Florian Grebien ,Bruno Di Stefano

Abstract

Post-transcriptional mechanisms are fundamental safeguards of progenitor cell identity and are often dysregulated in cancer. Here, we identified regulators of P-bodies as crucial vulnerabilities in acute myeloid leukaemia (AML) through genome-wide CRISPR screens in normal and malignant haematopoietic progenitors. We found that leukaemia cells harbour aberrantly elevated numbers of P-bodies and show that P-body assembly is crucial for initiation and maintenance of AML. Notably, P-body loss had little effect upon homoeostatic haematopoiesis but impacted regenerative haematopoiesis. Molecular characterization of P-bodies purified from human AML cells unveiled their critical role in sequestering messenger RNAs encoding potent tumour suppressors from the translational machinery. P-body dissolution promoted translation of these mRNAs, which in turn rewired gene expression and chromatin architecture in leukaemia cells. Collectively, our findings highlight the contrasting and unique roles of RNA sequestration in P-bodies during tissue homoeostasis and oncogenesis. These insights open potential avenues for understanding myeloid leukaemia and future therapeutic interventions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。